Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on May 31st, 2018%
A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems. . . . → Read More: Data Tools Designed for Genomics-Based Precision Cancer Care
By Alan, on May 31st, 2018%
The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases
By Alan, on May 31st, 2018% It’s important to choose the right machinery for your needs while keeping within your budget. . . . → Read More: A Guide To Buying Industrial Machinery
By Alan, on May 30th, 2018%
A technology for cancer therapies that harnesses the immune system with nanoscale droplets suspended in an emulsion and delivered through the nose received a U.S. patent. . . . → Read More: Patent Awarded for Nasal Delivered Cancer Immunotherapy
By Alan, on May 30th, 2018%
A new three-dimensional modeling and printing process can produce more accurate models of human anatomy in less time and with less effort than current techniques. . . . → Read More: 3-D Print Advance Creates More Accurate Medical Models
By Alan, on May 30th, 2018% The fundamental difference between small business owners and employees vs. investors and big business owners is that the small business owner and employee are both trading time for money in a very linear and transactional way. . . . → Read More: Investing – The Path To True Wealth
By Alan, on May 29th, 2018%
Results from a clinical trial show an experimental treatment for an aggressive form of brain cancer that harnesses the immune system extends patients’ survival, when combined with standard cancer care. . . . → Read More: Immunotherapy Trial Shows Increased Brain Cancer Survival
By Alan, on May 29th, 2018%
A new formulation of a current drug to treat amyotrophic lateral sclerosis, or ALS, shows in its first clinical trial the drug produces more active ingredients against ALS than the current drug and causes no safety concerns. . . . → Read More: New ALS Drug Formula Shown Active, Safe
By Alan, on May 29th, 2018% A lot of people don’t actually know what makes a good web site and they just think of all of the cosmetic stuff but a good web site is about more than just design. . . . → Read More: Four Ingredients That Every Good Web Site Needs
By Alan, on May 28th, 2018%
Today is Memorial Day in the U.S., so Science & Enterprise is not posting any new items. . . . → Read More: Memorial Day 2018
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|